Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Acquisition provides Orexigen ownership of CONTRAVE in nearly all major global markets
Takeda Moves to Strengthen Focus on Recent Launches
SAN DIEGO and DEERFIELD, Ill., and OSAKA, Japan, March 15, 2016 -- (Healthcare Sales & Marketing Network) -- Ore... Biopharmaceuticals, AcquisitionsOrexigen Therapeutics, Takeda Pharmaceutical, CONTRAVE, naltrexone, bupropion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news